AACR Releases Annual Cancer Progress Report Highlighting Promising Advances for Patients
FDA approved 11 new cancer drugs during the 12 months covered by the report, but continued progress will require...
FDA approved 11 new cancer drugs during the 12 months covered by the report, but continued progress will require...
Cycling fans can ride the iconic Philadelphia Cycling Classic course before the professional bicycle race starts on August 30...
First-ever AACR-sponsored clinical trial will test whether biomarker-directed treatment approaches can help patients skip surgery and preserve their organs...
Report features latest statistics, including promising signs of progress, and 10 compelling personal stories PHILADELPHIA – The American Association...
PHILADELPHIA – The American Association for Cancer Research (AACR) today thanked Emerging Frontiers in Oncology (EFO) for its support...
Keith T. Flaherty, MD, FAACR, begins term as AACR President SAN DIEGO – The members of the American Association...
Five new AACR Board of Directors members elected PHILADELPHIA – The members of the American Association for Cancer Research...
$12 million awarded to six collaborative teams developing new approaches to the earlier detection and diagnosis of pancreatic, ovarian,...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected 2026 class of Fellows of...
More than 30 new drugs have been approved for pediatric cancer in the past 10 years, but progress has...